查看購物車
  • English
  • Japanese
  • Korean
人工生物材料：在醫療領域的潛力：市場與技術（2027-2047）
市場調查報告書
商品編碼
2105109

人工生物材料：在醫療領域的潛力：市場與技術（2027-2047）

Engineered Living Material: Medical Opportunities: Markets, Technology 2027-2047
出版日期: | 出版商: Zhar Research | 英文 241 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

概括

我們能否活到120歲？我們能否培育出根據個人需求量身訂製的卓越器官？我們能否治癒目前尚無有效療法的疾病？這份長達241頁的報告說明了人工生物材料（ELMs）帶來的這些可能性及其相關的商業機會。 ELMs有時也被簡稱為「生命材料」。它們是一種能夠生長和成形以滿足特定用途，並在使用過程中保持活性的材料。本報告力求清晰易懂，主要面向對ELMs（或構成ELMs的高附加價值生物材料和非生物材料）的生產、銷售和應用感興趣的公司和相關人員。

本報告對考慮投資ELM領域的投資者、監管機構、產業分析師、研究人員、產品整合商以及新興價值鏈中的其他相關人員同樣具有參考價值。報告優先提供具有商業性實用價值的信息，即使不具備生物學或醫學等關鍵領域的專業知識，也能憑藉基本的科學知識理解，而非深入探討歷史過程或複雜的專業術語。報告清楚地指出了許多挑戰，同時也揭示了新的商業機會。為了提供更多信息，報告引用並評估了2025年和2026年發表的多篇研究論文，並介紹了Zhar Research醫療設備系列的其他近期報告。

ELM的多功能性降低了投資風險。

Zhar Research執行長暨首席作者Peter Harrop博士表示：「ELM（內生器官）有望成為我們延長壽命、提高健康水平的關鍵，並將為社會帶來巨大的益處。其中一項益處是能夠培育出比移植器官更豐富的優質器官。但其商業化潛力遠不止於此。在此之前，還有許多應用可以實現。

清晰的分析和專家見解

本報告基於博士級的分析和預測，運用全新的資訊圖表、SWOT分析、藍圖、圖表、對比表格以及簡明易懂的要點總結，對ELM領域進行了清晰簡潔的概述。尤其值得一提的是，本報告深入研究了2025年和2026年的最新全球研究成果，並持續更新信息，確保讀者始終掌握最新資訊。 ELM是一個快速發展的領域，研發開發平臺也在迅速成長；因此，過時的資訊可能會嚴重扭曲現狀。儘管目前ELM及其組成材料的生產企業數量有限，但一些有用的新技術正在湧現，本報告也對這些企業進行了介紹。本分析並非盲目讚揚ELM，而是提供客觀公正的評估。本報告定位為一份以商業為導向的實用指南，旨在幫助企業儘早進入這個潛力巨大的市場，未來可能成長至數十億美元。

目錄

第1章：執行摘要與結論

  • 本報告的目的
  • 分析方法
  • ELM 定義、基本分類、SWOT 分析
  • 仿生ELM的設計方法
  • 創建和實施 ELM 的四個階段
  • 整合到 ELM 中的功能
  • ELM 的目的與應用
  • ELM在科學和醫學領域的作用
  • 主要結論：運用新穎的資訊圖和圓餅圖對新興的ELM市場進行分析。
  • 主要結論：利用新型資訊圖、SWOT 分析和圓餅圖分析對 ELM 進行設計、材料和製造。
  • 醫學領域ELM藍圖
  • 市場預測及說明和解釋
    • 市場結構與不確定性
    • ELM在醫療應用的應用：對培養器官植入和其他應用進行精確預測
    • ELM在醫療領域的應用：培養器官植入及其他用途的預測呈上升趨勢
    • 通用自修復材料市場：ELM與整體市場的比較
    • 醫用自癒材料市場：以病人為導向的材料與以建築/設備為導向的材料的比較
    • ELM 醫療用途市場的區域構成比
    • 用於醫療用途的ELM製造商數量

第2章：定義、自然啟發、再生醫學及ELM進展

  • 工程化生命材料的定義與基本分類
  • ELM 的目的與應用
  • ELM在科學和醫學領域的作用
  • ELM的快速發展趨勢
  • 從大自然中汲取靈感：延長壽命和自我修復
    • 生物材料的設計原則
    • 海藻、巨龜、蠑螈、海參、水母、海星、水蠑螈、斑馬魚、海蜘蛛、刺鼠
    • ELM位於生物體和非生物體的邊界處
  • 仿生ELM及相關研究進展實例
    • 模仿章魚的自癒軟體機器人：在外科手術、義肢和義肢的應用
    • 積極研發自修復材料及ELM定位
  • 再生醫學的現況與未來展望
    • 定義和重點領域
    • 再生醫學的發展趨勢
    • 再生醫學和ELM

第3章：人工生物材料（ELMs）基礎知識

  • 概述：ELM設計方法
  • ELM進展範例
  • 生物ELM與混合HLM的比較
  • 真核生物和原核生物
  • ELM 內建的一些功能
  • 創建和部署 ELM 的四個階段
  • 水凝膠為何作為ELM支架材料而廣受歡迎
  • 真菌ELM的重要性
  • 生物成像、細胞感測和其他光學操控
  • 殘疾與未來前景

第4章：ELM研究進展帶來的商業機會

  • 來自 ELM 研究和行業舉措的見解
  • 生物醫學ELM的SWOT分析
  • 早期ELM研究案例比較
  • 標靶治療在生物醫學ELM研究領域的進展
    • 關節軟骨修復
    • ELM在生物修復和生物治療的應用
    • 利用生物水凝膠進行生物電神經刺激和生理血壓訊號檢測
    • 癌症免疫療法
    • 具有生物功能的自潤滑隱形眼鏡
    • 能夠根據檢測到的需求即時輸送藥物。
    • 免疫工程
    • 感染性角膜炎的治療
    • 發炎性腸道疾病
    • 微/奈米機器人：標靶治療、微創介入、醫療圖像
    • 皮膚病
    • 陰道失衡及其他症狀
    • 創傷治療：生物繃帶、工程血塊（EBC）、牙科應用
  • 生物醫學ELM研究的進展不僅限於特定療法
    • ELM功能增強
    • 人工智慧設計為ELM帶來新的可能性
    • ELM中使用的細菌種類
    • 利用仿生局部組裝的高級生物醫學ELM
    • 透過生物工程開發的生物材料
    • 闡明受限條件下的細胞增殖機制。
    • ELM（體外膜團）是一個涉及多個菌株的協作過程。
    • 一種能夠實現自我生長和機械性能調節的活性載體基質。
    • 製備 ELM 聚合物基質以控制微生物黏附、生長、空間排列和表現型。
    • 可直接從活細胞生長的可程式設計ELM
    • 合成生物學在ELM的應用
  • 生物醫學ELM相關研究進展

第5章：ELM結構製造技術

  • 概述：積層製造程序，如合成、光刻、靜電紡絲等技術。
  • 3D/4D列印ELM（含生物墨水製備）
  • 一種將細菌培養成公分級結構的科技。
  • 其他技術

第6章：新興醫療ELM製造商

  • 概述
    • The Advanced Regenerative Manufacturing Institute (ARMI)
    • European Innovation Council (EIC)
    • Wyss Institute at Harvard University
  • 生產ELM及相關產品的公司
    • Bluepha
    • Ecovative Design
    • Evonik Industries
    • Ginkgo Bioworks
    • GsynBioT
  • 擁有與ELM相關技術的公司
    • AMSilk Germany
    • Aquestive Therapeutics USA
    • Arsenal Medical USA
    • Biomason USA
    • Caravan Biologix USA
    • MDimune South Korea
    • Modern Synthesis UK
    • Mycoworks (DFX Corporation) USA
    • PhaBuilder China
    • Zhejiang Chuanhua Yixin New Materials Co., Ltd China.
簡介目錄

Summary

Live to the age of 120 years? Have better organs grown for you? Treat currently incurable diseases? The unique 241-page report, “Engineered Living Material: Medical Opportunities: Markets, Technology 2027-2047” details these and allied commercial opportunities from Engineered Living Materials ELM. Some call them simply Living Materials. Grown-to-purpose, they are alive during use. This easily-understood guide is primarily for those wishing to manufacture, market and use ELM or their constituent added-value materials both living and inanimate.

There is also much to interest those wishing to invest in ELM, the legislators, commentators, researchers, product integrators and others in the emerging value chain. The report shuns history and technical obscurity to provide commercially-useful information to those that do not necessarily have a deep technical background in the key subjects such as biology or medicine but do have the science basics. It includes many identified challenges that are your opportunities. Your route to even further detail is the large numbers of 2025 and 2026 research papers cited and assessed and other new Zhar Research reports from the Zhar Research medical hardware series shown.

ELM virtuosity derisks investment

Dr Peter Harrop, primary author and Zhar Research CEO advises, “ELM can be the key to us living much longer and more healthily, with massive benefits to society. One part of that is growing organs that are more abundant and of better quality than transplants, but there is more – much more - that can be commercialised before that. One example is ELM drug delivery responsive to need in real time, as sensed by that ELM. From cancer to contact lenses and wound therapies, all detailed here, the sheer scope of ELM derisks your investment.

”

Unique clarity and expert insight

The emphasis is clarity and insight provided by PhD level analysis and forecasts presented as new infograms, Success Weakness Opportunity Threat SWOT appraisals, roadmaps, graphs, comparison tables and detailed bullet conclusions in simple language. Importantly, there is a very thorough look at the very latest research worldwide for 2025 and 2026 with constant updates, so you only get the latest. Old information can be very misleading in what is now a rapidly advancing subject with a surging pipeline of research and some useful new advances from the rather small number of companies involved – and profiled here - that are manufacturing ELM and their constituent parts. This analysis provides balanced judgement not evangelism. You are invited to get in at the beginning of this multi-billion-dollar addressable market, not least by addressing the impediments identified in this report, your essential, commercially-oriented guidebook into the subject.

The chapters

The Executive Summary and Conclusions (37 pages) is sufficient for those in a hurry, for here are the basics, mainly as infograms, the 18 forecast lines 2027-2047 as tables and graphs with explanation and the 19 key conclusions split into market and then technical/ company aspects with analysis pie charts including relative popularity of scaffold/ matrix materials and the living materials they support, manufacturers by territory and so on – facts-based research.

The rest of the report is strongly powered by a close look at the flood of ELM research that arrived in 2026 and 2025 adding new benchmarking and manufacturer analysis. The Introduction (47 pages) gives the ELM definition, introduces simple subsets, objectives and applications 2027-2047 and its place in science, healthcare and particularly regenerative medicine. See how ELM are trending strongly. It then puts ELM in context by benchmarking the longevity and self-healing abilities found in nature. Then come examples of biomimetic ELM and allied research progress including researchers copying the octopus to make soft robotics self-healing for surgery and prosthetics. The chapter ends with a close look at the strong pursuit of self-healing materials: putting ELM in this context with infograms and SWOT appraisal.

Chapter 3. Engineered Living Materials ELM Basics (39 pages) gives the detail on this with, examples of progress towards ELM, features created, ELM design approaches including bio-ELM vs hybrid HLM, architecture and materials, the living carrier matrix, eukaryotic vs prokaryotic, stages of creation and deployment. Learn why hydrogels are popular for ELM scaffolds and fungal ELM is important. Bio-imaging, cell-sensing, other photon manipulation are covered then obstacles and the way forward.

Chapter 4. Commercial Opportunities Arising from ELM Research Advances 2025-6 is a full 63 pages going into deep detail on your opportunities by type of therapy (13 important examples detailed). Then comes the large amount of new ELM advances 2024 through 2026 that are not specific to one therapy. Pie charts, SWOT, detailed tables and text clarify. 210 research papers are covered.

Chapter 5. Manufacturing Technology for ELM Structures (20 pages) goes beyond the synthesis of ELM as composite feedstock that has been covered earlier to the next stage of creating useful structures. That includes lithography, but with additive manufacture such as electrospinning being preferred (reasons given). See why 3D and 4D printed ELM are particularly favoured and understand including the bio-ink preparation and the alternatives such as growing bacteria into centimeter-scale structures.

Chapter 6. Medical ELM Manufacturers Emerging (22 pages) gives context and analysis and profiles organisations spinning off ELM companies. It then profiles ten leading ELM companies, showing that there is scope for far more.

Zhar Research report, “Engineered Living Material: Medical Opportunities: Markets, Technology 2027-2047” is your best guide. It is the only comprehensive, up-to-date report giving your opportunities with ELM, with extensive new insights, data and predictions not available from old reports or AI alone. It is written by someone with a track record of creating successful new companies.

CAPTION: Material from the Zhar Research report, “Engineered Living Material: Medical Opportunities: Markets, Technology 2027-2047” – cover, methodology and graphic of the self-healing aspect.

Table of Contents

1. Executive summary and conclusions

  • 1.1 Purpose of this report
  • 1.2 Methodology of this analysis
  • 1.3 Engineering Living Materials definition, simple subsets, SWOT appraisals
  • 1.4 Biomimetic ELM design approaches
  • 1.5 Four stages of ELM creation and deployment
  • 1.6 Features designed into engineered living materials
  • 1.7 Engineered Living Material objectives and applications 2027-2047
  • 1.8 ELM place in science and healthcare
  • 1.9 Primary conclusions: emerging ELM markets with new infograms and pie chart analysis
  • 1.10 Primary conclusions: ELM design, materials, manufacturing with new infograms, SWOT and pie chart analysis
  • 1.11 Roadmap for healthcare ELM 2027-2047
  • 1.12 Market forecasts in 18 lines 2027-2047 with explanation and commentary
    • 1.12.1 Market structure and uncertainties
    • 1.12.2 Healthcare ELM grown organ implants vs other $ billion cautious forecast 2027-2047
    • 1.12.3 Healthcare ELM grown organ implants vs other $ billion topside forecast 2027-2047
    • 1.12.4 Self-healing materials market for all applications: ELM vs total 2027-2047
    • 1.12.5 Self-healing materials for healthcare value market: patient vs buildings and equipment $ billion 2027-2047
    • 1.12.6 Percentage share of healthcare ELM value market by four regions 2027-2047
    • 1.12.7 Number of healthcare ELM manufacturers 2027-2047

2. Definitions, inspiration from nature, regenerative medicine, progress towards ELM

  • 2.1 Engineering Living Materials definition and simple subsets
  • 2.2 ELM objectives and applications 2027-2047
  • 2.3 ELM place in science and healthcare
  • 2.4 How ELM are trending strongly
  • 2.5 Inspiration from nature: longevity and self-healing
    • 2.5.1 Design principles of living materials
    • 2.5.2 Sea grass, giant tortoise, salamander, sea cucumber, jellyfish, starfish, hydra, zebra fish, sea spiders, spiny mouse
    • 2.5.3 ELM at the interface of living and inanimate
  • 2.6 Some examples of biomimetic ELM and allied research progress
    • 2.6.1 Researchers copy the octopus to make soft robotics self-healing for surgery, prosthetics
    • 2.6.2 Strong pursuit of self-healing materials: ELM in context
  • 2.7 Current regenerative medicine and ambitions for the future
    • 2.7.1 Definition and focus
    • 2.7.2 Regenerative medicine in
    • 2.7.3 Regenerative medicine and Engineered Living Materials

3. Engineered Living Materials ELM basics

  • 3.1 Overview: ELM design approaches
  • 3.2 Examples of progress towards ELM
  • 3.3 Bio ELM vs hybrid HLM
    • 3.3.1 Architecture and materials
    • 3.3.2 Later stage: the living carrier matrix
  • 3.4 Eukaryotic vs prokaryotic ELM
  • 3.5 Some features designed into engineered living materials
  • 3.6 Four stages of ELM creation and deployment
  • 3.7 Why hydrogels are popular for ELM scaffolds
  • 3.8 Importance of fungal ELM
  • 3.9 Bio-imaging, cell-sensing, other photon manipulation
  • 3.10 Obstacles and the way forward

4. Commercial opportunities arising from ELM research advances 2025-6

  • 4.1 Lessons from ELM research and industrial initiatives
  • 4.2 SWOT appraisal of biomedical Engineered Living Materials ELM
  • 4.3 Early examples of ELM research compared
  • 4.4 Biomedical ELM research advances 2025-6 by targetted therapy
    • 4.4.1 Articular cartilage (AC) repair
    • 4.4.2 Bioremediation and biotherapeutics ELM
    • 4.4.3 Bioelectrical nerve stimulation, physiological blood pressure signals by living hydrogels
    • 4.4.4 Cancer immunotherapy
    • 4.4.5 Contact lenses that are living and self-lubricating
    • 4.4.6 Drug delivery responding to sensed need in real time
    • 4.4.7 Immune engineering
    • 4.4.8 Infectious keratitis therapy
    • 4.4.9 Inflammatory bowel disease
    • 4.4.10 Micro/Nano-Robots: targeted therapy, minimally invasive intervention, medical imaging
    • 4.4.11 Skin disorders
    • 4.4.12 Vaginal imbalances and other conditions
    • 4.4.13 Wound healing: biobandages, Engineered Blood Clots EBC, dental
  • 4.5 Biomedical ELM research advances 2024 through 2026 not specific to one therapy
    • 4.5.1 Expanding the ELM functional toolbox
    • 4.5.2 AI design creates new ELM options
    • 4.5.3 Bacterial species in ELM
    • 4.5.4 Biomimetic localized assembly enhances biomedical ELM
    • 4.5.5 Bioengineered living materials
    • 4.5.6 Constrained cell growth unravelled
    • 4.5.7 Multistrain collaboration ELM
    • 4.5.8 Living carrier matrices enable self-growing and mechanically tunable ELM
    • 4.5.9 Tuning ELM polymer matrices to direct microbial adhesion, growth, spatial organization, and phenotype
    • 4.5.10 Programmable materials grown directly from living cells as ELM
    • 4.5.11 Synthetic biology for ELM
  • 4.6 71 Research advances 2024-6 somewhat relevant to biomedical ELM

5. Manufacturing technology for ELM structures

  • 5.1 Overview: synthesis, lithography, additive manufacture such as electrospinning, other options
  • 5.2 3D and 4D printed ELM including the bioink preparation
  • 5.3 Growing bacteria into centimeter-scale structures
  • 5.4 Other options

6. Medical ELM manufacturers emerging

  • 6.1 Overview
    • 6.1.1 The Advanced Regenerative Manufacturing Institute (ARMI) USA
    • 6.1.2 European Innovation Council (EIC) Europe
    • 6.1.3 Wyss Institute at Harvard University USA
  • 6.2 Companies making ELM and closely allied products
    • 6.2.1 Bluepha China
    • 6.2.2 Ecovative Design USA
    • 6.2.3 Evonik Industries Germany
    • 6.2.4 Ginkgo Bioworks USA
    • 6.2.5 GsynBioT China
  • 6.3 Companies with somewhat relevant technology to ELM
    • 6.3.1 AMSilk Germany
    • 6.3.2 Aquestive Therapeutics USA
    • 6.3.3 Arsenal Medical USA
    • 6.3.4 Biomason USA
    • 6.3.5 Caravan Biologix USA
    • 6.3.6 MDimune South Korea
    • 6.3.7 Modern Synthesis UK
    • 6.3.8 Mycoworks (DFX Corporation) USA
    • 6.3.9 PhaBuilder China
    • 6.3.10 Zhejiang Chuanhua Yixin New Materials Co., Ltd China.